Testicular Cancer

{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
{{header-clinical-trials-navigation}}

Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment


Condition: Childhood Cancer, Fertility Disorders

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03180918

Sponsor: Gumy-Pause Fabienne

Eligibility:

  • Age: minimum 3 Months maximum 18 Years
  • Gender: Male

Inclusion Criteria:

  • Prepubertal patients aged 3 months and older
  • Peri and pubertal patients after failure of sperm cryopreservation
  • Patients presenting high risk of infertility because of gonadotoxic treatments (i.e high dose of alkylating agents, testicular irradiation, total body irradiation).
  • Multidisciplinary team consensus in favour of proposition to cryopreserve testicular tissue

Exclusion Criteria:

  • Patients under the age of 3 months
  • Refusal of the patient and/or his parents
  • Treatments that are not highly gonadotoxic

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
email news signup